Cairo – Mubasher: The board of directors of Alexandria Co. for Pharmaceuticals and Chemical Industries approved the estimated budget for fiscal year 2021/2022.
The company aims to achieve EGP 208 million in net profits during the coming fiscal year, compared to a target of EGP 170 million in FY20/21, according to a bourse disclosure on Sunday.
The pharmaceutical company targets EGP 1.44 billion in revenue in FY21/22, compared to a target of EGP 1.2 billion in the current fiscal year.
During the first half (H1) of FY20/21, the company posted net profits of EGP 79 million, down from EGP 85.26 million in the corresponding period a year earlier.
